Cell death induced by taxanes in breast cancer cells: cytochrome C is released in resistant but not in sensitive cells
Jazyk angličtina Země Řecko Médium print
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
16309219
Knihovny.cz E-zdroje
- MeSH
- antitumorózní látky fytogenní farmakologie MeSH
- buněčná smrt účinky léků fyziologie MeSH
- buňky - růstové procesy účinky léků MeSH
- chemorezistence MeSH
- cytochromy c metabolismus MeSH
- docetaxel MeSH
- fragmentace DNA účinky léků MeSH
- inhibitor p21 cyklin-dependentní kinasy biosyntéza MeSH
- kaspasa 3 MeSH
- kaspasa 9 MeSH
- kaspasy metabolismus MeSH
- lidé MeSH
- nádorové buněčné linie MeSH
- nádorový supresorový protein p53 biosyntéza MeSH
- nádory prsu farmakoterapie metabolismus patologie MeSH
- paclitaxel farmakologie MeSH
- taxoidy farmakologie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- antitumorózní látky fytogenní MeSH
- CASP3 protein, human MeSH Prohlížeč
- CASP9 protein, human MeSH Prohlížeč
- CDKN1A protein, human MeSH Prohlížeč
- cytochromy c MeSH
- docetaxel MeSH
- inhibitor p21 cyklin-dependentní kinasy MeSH
- kaspasa 3 MeSH
- kaspasa 9 MeSH
- kaspasy MeSH
- nádorový supresorový protein p53 MeSH
- paclitaxel MeSH
- taxoidy MeSH
- TP53 protein, human MeSH Prohlížeč
BACKGROUND: The aim of the study was to contribute to our understanding of the mechanisms responsible for the resistance of breast cancer cells to taxanes. MATERIALS AND METHODS: Cell cycle characteristics, DNA fragmentation, p53 and p21(WAF1/CIP1) expression, caspase-3 and caspase-9 activity, cytochrome c release from mitochondria during cell death induction by the taxanes paclitaxel and docetaxel in highly-sensitive MDA-MB-435 and highly-resistant NCI-ADR-RES human breast cancer cells were compared. RESULTS: Approximately 300-fold higher concentrations of the taxanes were required to induce death in resistant NCI-ADR-RES cells than in sensitive MDA-MB-435 cells. Cell death induced by the taxanes in both sensitive and resistant cells was preceded by the accumulation of cells in the G2/M-phase. Neither cell type produced any DNA fragmentation (DNA ladder) typical of regular apoptosis. The p53 and the p21(WAF1/CIP1) levels did not change in sensitive or in resistant cells during cell death induction by the taxanes. The activity of the executioner caspase-3 increased significantly (2 to 2.5-fold) and, similarly, the activity of caspase-9 increased significantly (2 to 3.5-fold) in both cell types. However, cytochrome c was found to be released from mitochondria into the cytosol only in the resistant NCI-ADR-RES cells, but not in the sensitive MDA-MB-435 cells. CONCLUSION: The death induced by the taxanes in the studied breast cancer cells can be characterized as an apoptosis-like death, including caspase-3 and caspase-9 activation but not oligonucleosomal DNA fragmentation. However, the mechanisms of death induction by the taxanes in sensitive MDA-MB-435 cells and resistant NCI-ADR-RES cells differ. Cytochrome c is released from the mitochondria in resistant but not in sensitive cells.
The Role of TRIP6, ABCC3 and CPS1 Expression in Resistance of Ovarian Cancer to Taxanes
The role of individual caspases in cell death induction by taxanes in breast cancer cells
Cell death induced by novel fluorinated taxanes in drug-sensitive and drug-resistant cancer cells